Generics 21

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Daptomycin manufacturers

21 products found

Filters

21 products found

daptomycin

Vials 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 5 days

daptomycin

Vials, lyophilized injection 350 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 9 days

daptomycin

Vials, injection 350mg/ml, 500mg/ml - 20ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 8 days

Want to see all 21 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the drug Daptomycin?

Daptomycin is a lipopeptide antibiotic. It is used to treat bacterial infection of the skin caused by gram-positive microorganisms, Staphylococcus aureus, and bloodstream infection. It is administered only by intravenous processes. Daptomycin is a natural compound found in the saprotroph soil. Daptomycin was the first lipopeptide antimicrobial medication to be marketed. Today, it represents 83 % of in vitro antibiotics for gram-positive infections. Dasatinib medication is generally used to replace Gleevec when it is no longer efficient on patients or when the patients suffer from too strong side effects.

Wholesalers and manufacturers of Daptomycin

Daptomycin suppliers marketed it in the form of powder or injection for solutions. The medication is available either by its generic name, Daptomycin, first launched by Teva or by its brand name Cucibin marketed by Cubist Pharmaceuticals. Daptomycin was approved to be marketed in 2003 in the United States and in 2006 in the European Union.
The medication can be manufactured by Pfizer, Merck, and many others thanks to partnerships with Cubist. Counting only in China, there are more than 230 Daptomycin suppliers.

Daptomycin for sale:

The retail prices for one dose of Daptomycin intravenous powder for injection for 350 mg can fluctuate from $60 to $240, and for one dose of 500 mg, it can cost from $85 to $175, in the US market.
On Pipelinepharma online B2B marketplace, Daptomycin is mostly available from Turkey, where the medication was discovered. The platform helps Daptomycin distributors to find globally qualified manufacturers through quality control procedures. On the company website, you can find a list of many pharmaceutical products, including Daptomycin. If you are interested in this product, you can easily place an order on the Pipelinepharma platform to find Daptomycin manufacturers.

How to use Daptomycin drugs?

Depending on the Daptomycin treatment you follow, the use of the medication will be different. Taking Daptomycin for a skin and structure infection, an adult should take 4 mg/kg in vitro every 24 hours for 7 to 14 days.
If it is to treat Bacteremia, an adult should take 6 mg/kg IV every 24 hours for 2 to 6 weeks.
Daptomycin medication can have some side effects, the most common ones are: swelling of some body parts such as the face, arms, hands, lower legs, or feet, a fever, a rapid and unusual gain or loss of weight.
It must be stored in the refrigerator. If Daptomycin is mixed with a diluent, it still must be stored in the refrigerator but It must be taken within the following 48 hours.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation